NeuroSense Therapeutics, Ltd. (NRSN): Kapitalizatsiya va daromad nisbati
NeuroSense Therapeutics (NRSN) kompaniyasining P/S koeffitsiyentini monitoring qilish shuni ko'rsatadiki, aksiyalar narxi patent himoyasidagi sektorda klinik sinovlarning muvaffaqiyatiga bog'liq bo'lib, joriy daraja ni tashkil etadi. Moliyaviy salohiyat ALS terapiyasi bo'yicha kelajakdagi monopoliyaga va dori vositalari narxini mustaqil ravishda belgilash imkoniyatiga tayanadi. R&D pipeline'ning yuqori samaradorligi va kombinatsiyalangan PrimeC dorisini ishlab chiqishdagi yutuqlar biznesning fundamental barqarorligini tasdiqlaydi.
NeuroSense Therapeutics (NRSN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati NeuroSense Therapeutics|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati neurosense-tx.com|NRSN - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati NeuroSense Therapeutics, Ltd.|NRSN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz NeuroSense Therapeutics|Oraliq qoplash koeffitsiyenti neurosense-tx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
NRSN - Sof foyda|Prognoz qilingan kelajakdagi foyda NeuroSense Therapeutics|NRSN - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati neurosense-tx.com|NRSN - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati NeuroSense Therapeutics, Ltd.|NRSN - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) NeuroSense Therapeutics|NRSN - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati neurosense-tx.com|NRSN - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi NeuroSense Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:NeuroSense Therapeutics Ltd, NRSN
Investorlar NeuroSense Therapeutics (NRSN) kompaniyasining barqarorligini uning aktivlarining bozor qiymati prizmasi orqali bahlamoqdalar. P/S koeffitsiyenti umumiy bozor kapitalizatsiyasini yillik savdo hajmi bilan bog'lab, bozorning daromadning bir birligi uchun to'lashga tayyor bo'lgan premiumini aniqlaydi. Daromad multiplikatori darajasini tahlil qilish narxlardagi anomaliyalar va haddan tashqari yuqori baholash risklarini aniqlash imkonini beradi. ALS terapiyasi sohasida monopoliya salohiyatiga ega bo'lgan biotexnologiya firmasi uchun ushbu ko'rsatkich eksklyuziv narx belgilash imkoniyatiga oid kelajakdagi kutishlarni aks ettiradi.
Raqobatdosh kompaniyalar
BIIB - Sotuvga nisbatan narx|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC: Kapitalizatsiya va daromad nisbati|AXSM - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti ACADIA Corp ACAD|XENE: P/S multiplikatori|Sotuvga nisbatan narx vikingtherapeutics.com (VKTX)|Kapitalizatsiyaning daromadga nisbati SUPN|CPRX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati DNLI (Denali Therapeutics Inc)|Kapitalizatsiyaning sotish hajmiga nisbati HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|Bozor kapitallashuvining daromadga nisbati AMLX|Trevi Therapeutics, Inc. - P/S multiplikatori|Sotuvga nisbatan narx Praxis Precision Medicines Inc|Anavex Corp (AVXL) - Narxning daromadga nisbati|CeriBell EEG - Bozor kapitallashuvining daromadga nisbati|PRTA (Prothena Biosciences) - P/S multiplikatori|P/S multiplikatori Alector Therapeutics|Narxning daromadga nisbati Annexon (ANNX)|OMER: Narxning sotuvga nisbati|P/S multiplikatori NGNE (Neurogene Corp)|AC Immune Inc (ACIU) - Sotuvga nisbatan narx|VYGR: Kapitalizatsiyaning daromadga nisbati|NMRA - P/S multiplikatori|SCLX (Scilex) - Kapitalizatsiyaning daromadga nisbati|TVGN: Kapitalizatsiyaning sotish hajmiga nisbati|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Cognition Therapeutics Inc. (CGTX) - Narx/daromad koeffitsiyenti|P/S multiplikatori IKT|Kapitalizatsiyaning daromadga nisbati cassavasciences.com SAVA|Narxning daromadga nisbati Assertio ASRT|Narx/daromad koeffitsiyenti Coya Therapeutics Inc (COYA)|VTGN - Narxning daromadga nisbati|OVID (Ovid Therapeutics Inc.) - Kapitalizatsiya va daromad nisbati|Acumen Pharmaceuticals (ABOS) - Narxning daromadga nisbati|cervomed.com - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Ltd.|Clene Nanomedicine (CLNN) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati PepGen Inc. (PEPG)|Jupiter Neurosciences, Inc. - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Relmada Therapeutics RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|Sotuvga nisbatan narx Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Kapitalizatsiyaning daromadga nisbati|Reviva Pharmaceuticals, Inc. (RVPH) - P/S multiplikatori|Narxning daromadga nisbati MetaVia Inc.|NRXS: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Helius Medical (HSDT)|PASG - Sotuvga nisbatan narx|Narxning daromadga nisbati Neuphoria Therapeutics NEUP|NERV: Kapitalizatsiya va daromad nisbati|Athira Pharma, Inc. - P/S multiplikatori|Sotuvga nisbatan narx addextherapeutics.com|ALZN (alzamend.com) - Kapitalizatsiyaning daromadga nisbati|Cyclerion Therapeutics, Inc. (CYCN) - P/S multiplikatori|Narxning daromadga nisbati Protagenic Therapeutics Inc.|KTTA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Cortigent, Inc. (CRGT)|ATXI - Sotuvga nisbatan narx|Narxning daromadga nisbati BrainStorm Cell Therapeutics BCLI|Narx/daromad koeffitsiyenti Cara Therapeutics Inc. (CARA)|Chromocell Therapeutics Corporation - P/S multiplikatori|Sotuvga nisbatan narx Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati LBPH|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGen Biotech Inc (NKGN) - Narx/daromad koeffitsiyenti|P/S multiplikatori NRBO|SAGE - Sotuvga nisbatan narx|Synaptogenix, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati TRVN|VIGL: Kapitalizatsiyaning daromadga nisbati|anewmeds.com - Kapitalizatsiyaning sotish hajmiga nisbati|CERE: P/S multiplikatori
